Background: The BIOSECURE Act and the push for reshoring manufacturing to the US are driving complexities in pharmaceutical manufacturing. International technology transfers require effective coordination among cross-functional teams and become more complex across global sites due to evolving regulations and operational constraints, increasing the risk of misalignment and inefficiencies that can negatively affect time to market, product quality, and patient outcomes. To address these issues, Syner-G | Sequoia have developed a technology transfer playbook offering a strategic framework for effective planning and execution. Supported by proven case studies, this approach turns challenges into opportunities for effective implementation, improving outcomes for both organizations and patients.
